New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control Epilepsy
Links shared publicly online about this topic.
- 286total visits
New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control Epilepsy
GlaxoSmithKline has today launched Trobalt® (retigabine), the first in a new class of anti-epileptic drug (AED), for the adjunct treatment of adults with partial-onset seizures, and demonstrat
View full resource at medicalnewstoday.com
Tags: Seizure, Epilepsy, Drug, GlaxoSmithKline, Epilepsy Medication
Most Recently Shared on May 17, 2011 at 6:14 pm By:
New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Con... http://bit.ly/lIJh2k
New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control Epilepsy
medicalnewstoday.com — “GlaxoSmithKline has today launched Trobalt® (retigabine), the first in a new class of anti-epileptic drug (AED), for the adjunct treatment of adults with partial-onset seizures, and demonstrat” View full resource at medicalnewstoday.com
Most Recently Shared on May 17, 2011 at 11:05 am By:
New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control E... http://mnt.to/3VXs
Advertisement
